In the final days of 2024, three pharmaceutical giants sued the federal government. In their joint lawsuit, Amgen, Eli Lilly ...

The federal 340B drug pricing program is failing to meet the needs of the vulnerable patients the program was intended to ...

Proximity, founded by a Kalderos alum, identifies savings opportunities and potential compliance issues for health care ...

When the 340B program was first launched, pharmaceutical manufacturers were to provide medications at a discounted price for ...

The industry could see payment, workforce and insurance coverage changes depending on how the Trump administration weighs in ...

While our healthcare institutions strive to serve their communities, the 340B Drug Pricing Program needs reform to better ...

In 2023, the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee opened an investigation into how 340B revenue is spent to help patients.

Proximity launched to help healthcare providers uncover and secure missed revenue from the Federal 340B Drug Pricing Program.

In his welcoming remarks, AHA President and CEO Rick Pollack discussed some of the immediate threats to rural hospitals' well ...

The Senate has approved a $340 billion budget blueprint to fund the first part of President Trump’s agenda. The resolution ...

The AHA Feb. 24 filed a friend-of-the-court brief in the Supreme Court, urging the court to reverse a ruling by the U.S. Court of Appeals for the 5th Circuit that would jeopardize cost-free access to ...